|
The role of Src kinase in estrogen receptor-positive breast cancer proliferation
|
5F31CA180740-03
|
$31,866
|
$31,866
|
ABDULLAH, CHRISTOPHER
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
1R01CA172105-01A1
|
$401,456
|
$401,456
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
5R00CA172697-03
|
$249,000
|
$124,500
|
ACHARYYA, SWARNALI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
5R01CA171651-03
|
$603,662
|
$603,662
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-05
|
$870,850
|
$87,085
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS
|
5R01CA172623-03
|
$392,520
|
$392,520
|
AFT, REBECCA
|
WASHINGTON UNIVERSITY
|
|
Fat transplant for glitazone delivery and adiponectin production to inhibit breas
|
1R21CA187829-01A1
|
$162,038
|
$162,038
|
AGARWAL, JAYANT
|
UNIVERSITY OF UTAH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$147,440
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Organ specific macrophages and the regulation of disseminated tumor cell fate
|
1R03CA191430-01
|
$84,750
|
$84,750
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
|
5R01CA172119-03
|
$692,667
|
$692,667
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
5R01CA152312-05
|
$355,348
|
$355,348
|
AKTAS, BERTAL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Estrogen Receptor Alpha Proteostasis in Breast Cancer
|
5R01CA159578-05
|
$310,848
|
$310,848
|
ALARID, ELAINE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
$21,503
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Vitamin D Pooling Project
|
ZIA CP010195 - 10436
|
$23,415
|
$5,854
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S1
|
$34,031
|
$6,126
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S2
|
$250,000
|
$45,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S3
|
$124,997
|
$22,499
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-07
|
$1,495,000
|
$269,100
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$323,966
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-05S2
|
$256,783
|
$38,517
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
3R01CA148994-05S1
|
$96,798
|
$96,798
|
ALIZAD, AZRA
|
MAYO CLINIC ROCHESTER
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
5R01CA148994-05
|
$390,161
|
$390,161
|
ALIZAD, AZRA
|
MAYO CLINIC ROCHESTER
|
|
Interleukin-4 Drives Tumor-Associated Macrophage Polarization to Promote Tumor Gr
|
5F30CA173910-02
|
$48,056
|
$48,056
|
ALLEN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
Targeting defective DNA repair for the prevention of BRCA1-associated cancers
|
1K22CA181550-01
|
$162,000
|
$81,000
|
ALLI, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$34,355
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
$5,550
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
$103,134
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$60,000
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$149,340
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
5P01CA151135-05
|
$3,169,913
|
$3,169,913
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$483,603
|
$483,603
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$192,212
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases
|
5K23CA157728-05
|
$173,598
|
$173,598
|
ANDERS, CAREY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI
|
3UM1CA173642-03S1
|
$113,842
|
$20,492
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-03
|
$2,539,856
|
$457,174
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
|
5R01CA156661-06
|
$562,767
|
$562,767
|
ANDREANA, PETER
|
UNIVERSITY OF TOLEDO
|
|
Dissecting Tumor Heterogeneity by Analyzing Signaling Pathway Requirements.
|
5R01CA160514-04
|
$312,582
|
$312,582
|
ANDRECHEK, ERAN
|
MICHIGAN STATE UNIVERSITY
|
|
LEGACY: A cohort of youth in families from the Breast Cancer Family Registry
|
5R01CA138844-05
|
$347,733
|
$347,733
|
ANDRULIS, IRENE
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
Enhancing prognostic power of tumor grade by revisiting Ki67-mitosis relationship
|
1R03CA188527-01A1
|
$74,000
|
$74,000
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
|
3R01CA169127-04S1
|
$48,106
|
$48,106
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
3U01CA179671-02S1
|
$47,698
|
$47,698
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
|
5R01CA169127-04
|
$299,838
|
$299,838
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-02
|
$307,100
|
$307,100
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Interactive CD-ROM for Coping with Breast Cancer
|
3R44CA097701-04S1
|
$76,907
|
$76,907
|
ANGELL, KARYN
|
MPOWER, LLC
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$174,715
|
$34,943
|
Annunziata, Christina
|
CCR (NCI)
|
|
Non-canonical functions of EZH2 in triple-negative breast cancer
|
1F30CA196084-01
|
$33,721
|
$33,721
|
ANWAR, TALHA
|
UNIVERSITY OF MICHIGAN
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$83,659
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$451,895
|
$225,947
|
Appella, Ettore
|
CCR (NCI)
|
|
SPORE in Breast Cancer
|
5P50CA098131-13
|
$2,185,000
|
$2,185,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
5R01CA154738-05
|
$562,844
|
$562,844
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Breast for this search: $543,568,421
|